RVMD today
$176.35-$4.35 (-2.41%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourAscending Triangle
1 hourLeaning Bullish
15 minBearish
5 minConsolidating
Daily trend turns up above $211.51
Key levels
Resistance$197.97
Resistance$181.00
Support$166.50
Support$141.44
Latest news & SEC filings
SEC FilingRevolution Medicines, Inc. filed an insider trading report (Form 4)
LegalRegulator Halts Accelerated Medicine Approval Program
LegalFDA reportedly ends fast-track drug review pilot amid leadership vacancy
AnalystHC Wainwright keeps Buy rating on Revolution Medicines, lifts price target
All RVMD news →About Revolution Medicines
Revolution Medicines is a clinical-stage biopharmaceutical company developing targeted therapies for cancer. Its main product candidates are RAS(ON) inhibitors, including daraxonrasib, elironrasib, and zoldonrasib, which are being evaluated as single agents and in combination with other cancer treatments. The company operates in the United States and conducts clinical trials internationally, targeting patients with cancers driven by RAS mutations.
Based on the company's 10-K filed Feb 25, 2026.
Nasdaq · Healthcare
Revolution Medicines, Inc. (RVMD)
What Is the Price Target for RVMD?
SEPT Low Target
$179.00
SEPT Mid Target
$265.00
SEPT High Target
$350.00
Analyst Consensus
$265.00
Is RVMD a Buy or Sell Right Now?
Thesis
- •Revenue growing -67.3% YoY with DECLINING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for RVMD.
Start Free Trial →Is RVMD Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$205.96
10
Moat Score
NONE
1/9
Piotroski Score
26.1
Altman Z-Score
What Is Smart Money Doing with RVMD?
Insider Signal
SELLING
0 buys / 16 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
HIGH
Signal: HIGH_SHORT_INTEREST
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Mancini Anthony | officer | Buy | 810 | $27K | Nov 9, 2026 |
| Mancini Anthony | officer | Buy | 1 | $102.02 | Nov 9, 2026 |
| Mancini Anthony | officer | Sale | 811 | $162K | Nov 9, 2026 |
| Mancini Anthony | officer | Buy | 2,310 | $78K | Oct 26, 2026 |
| Mancini Anthony | officer | Sale | 2,310 | $432K | Oct 26, 2026 |
| Sandler Alan B. | officer | Buy | 6,000 | $353K | Sep 29, 2026 |
| Sandler Alan B. | officer | Sale | 2,200 | $442K | Sep 29, 2026 |
| Sandler Alan B. | officer | Sale | 1,609 | $325K | Sep 29, 2026 |
| Sandler Alan B. | officer | Sale | 1,000 | $203K | Sep 29, 2026 |
| Sandler Alan B. | officer | Sale | 1,199 | $244K | Sep 29, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →RVMD Growth Story
Revenue YoY
-67.3%
3yr Revenue CAGR
N/A%
EPS Growth YoY
-66.2%
FCF Growth YoY
-60.9%
Revenue Trend
DECLINING
Dark Pool Trades for RVMD
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for RVMD, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 21:26:15 | $176.35 | 20,049 | $$3.5M | SELL |
| 21:08:01 | $176.35 | 24,208 | $$4.3M | BUY |
| 21:00:22 | $176.35 | 1,050 | $$185K | SELL |
| 21:00:21 | $176.35 | 1,320 | $$233K | SELL |
| 20:59:10 | $176.27 | 3,000 | $$529K | SELL |
5 dark pool trades shown · $$8.8M preview volume
Real-time institutional flow, block trades, and net positioning
Options Flow for RVMD
PREVIEWSEPT Investing provides real-time options flow tracking for RVMD, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.
| Type | Strike | Expiry | DTE | Premium | Size | Trade |
|---|---|---|---|---|---|---|
| PUT | $165 | Dec 18 | 36 | $$620 | 1 | SWEEP |
| CALL | $200 | Dec 18 | 36 | $$430 | 1 | SWEEP |
| PUT | $165 | Dec 18 | 36 | $$612 | 1 | SWEEP |
| CALL | $200 | Dec 18 | 36 | $$430 | 1 | SWEEP |
| CALL | $200 | Dec 18 | 36 | $$430 | 1 | SWEEP |
5 options trades shown · 60% calls
Unusual activity, GEX levels, max pain, and dealer positioning
What Traders Are Saying About RVMD
2 postsSEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for RVMD. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.
Zone Setup -- $RVMD (Revolution Medicines, Inc.) Price: $189.24 | Zone: $168.19 to $192.80 Conviction: HIGH | Analyst upside: +-5.5% Near resistance (86% of range) — breakout watch. Strong positive ...
SEPT Brain on $RVMD -- Bullish Strong buying continues into $154.71. Uptrend holds while above $152.62. $200 psychological level is the next resistance to watch. The Play: Three scenarios from here:...
Join 3,500+ traders discussing RVMD in real-time
Trade ideas, setups, dark pool alerts, and AI-powered analysis
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Revolution Medicines, Inc. (RVMD) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →RVMD — frequently asked questions
What is RVMD stock price today?
Revolution Medicines, Inc. (RVMD) is at $176.35, down 2.41% (-$4.35) at the Nov 12, 2026 close.
Why is RVMD stock moving today?
Latest RVMD news — Nov 12, 2026: Revolution Medicines, Inc. filed an insider trading report (Form 4) · Nov 12, 2026: Regulator Halts Accelerated Medicine Approval Program
Why did RVMD stock move on Oct 20, 2026?
Revolution Medicines shares surged 8.31% today, closing at $196.59 on volume of 2,512,949, after the company announced it has begun a final-stage human study of its therapy for advanced lung cancer. The Phase 3 zoldonrasib study, known as RASolve 308, has started dosing patients in combination with pembrolizumab and chemotherapy for advanced NSCLC that has spread, marking the last testing step before a possible regulatory filing.
What is the RVMD price target?
The average analyst price target for RVMD is $265.00, ranging from $179 to $350, based on 17 analysts. Latest: HC Wainwright & Co. maintains on Nov 6, 2026.
What do analysts rate RVMD?
Analyst ratings for RVMD: 0 Buy, 61 Hold, 0 Sell — consensus Hold.
Did RVMD beat earnings?
RVMD last reported on Nov 4, 2026: EPS -$1.90 vs -$2.35 expected — a beat of 19.1%.
Does RVMD pay a dividend?
RVMD does not currently pay a dividend.
What are RVMD support and resistance levels?
Support: $166.50, $141.44, $120.63. Resistance: $181.00, $197.97, $211.41.
What are insiders doing with RVMD?
Insider activity: SELLING, 0 buys and 16 sells in the last 90 days.
What is the latest news on RVMD?
Nov 12, 2026: Revolution Medicines, Inc. filed an insider trading report (Form 4) · Nov 12, 2026: Regulator Halts Accelerated Medicine Approval Program · Nov 12, 2026: FDA reportedly ends fast-track drug review pilot amid leadership vacancy